Applications Invited for Pfizer Medical Education Grant on Bladder Cancer MIBC and la/mUC

Applications Invited for Pfizer Medical Education Grant on Bladder Cancer MIBC and la/mUC

Organization: Pfizer

Apply By: 10 Nov 2026

Grant Amount: 1000 USD

About the Organization

Pfizer's purpose is breakthroughs that change patients’ lives. We pursue that goal relentlessly and innovate every day to make the world a healthier place. It was Charles Pfizer’s vision at the beginning and it holds true today.

About the Grant

This is a competitive grant program for independent medical education. It aims to raise awareness and knowledge among healthcare professionals about gaps in the fast-changing bladder cancer treatment landscape, using new and existing data to improve care for patients with MIBC and la/mUC. The grantee designs and runs the education independently, and Pfizer must not be involved in developing or delivering it.

Areas of interest:

- Gaps in awareness and knowledge in MIBC: - Limits and unmet needs in current treatment, including patient groups with few or no options. - The role of antibody-drug conjugates (ADCs) and their mechanism of action. - Use of perioperative therapies and their effect on outcomes. - Managing adverse events of perioperative therapies. - Communication and shared decision-making between urology, medical oncology, the multidisciplinary team, patients and caregivers. - Guideline-recommended care in first-line la/mUC: - - Holistic management, including therapy selection and sequencing, and early identification and monitoring of adverse events. - Best practices for multidisciplinary teams, especially in community and rural settings, with a focus on advanced practice provider education. - Stronger shared decision-making between providers and patients and caregivers.

Target audience:

Surgical urologists, urologists, uro-oncologists, medical oncologists, advanced practitioners (PAs and NPs), nurses and other multidisciplinary team members who care for patients with urothelial cancer.

Eligibility

- Geographic scope is the United States only.

- Eligible organizations are:

- Only organizations can receive grants. Individuals and independent physician practice groups are not eligible. - The applicant must be the project lead or an authorized designee. The lead must be an employee or contractor of the requesting organization. - In multi-institution projects, every institution must have a relevant role, and the requesting organization must have a key role. - The organization must be legally able to receive funds directly from Pfizer Inc. Grants can be rescinded if it is not. - Projects offering continuing education credit must be run by an accredited organization. - - Medical, nursing, allied health and pharmacy schools. - Healthcare institutions. - Professional organizations and medical societies. - Medical education companies. - Other entities with a healthcare education or improvement mission.

Funding:

- Individual requests of $10,000 to $230,000 will be considered. Multi-support is accepted. - The total budget available for this RFP is about $900,000. - Awards include direct costs, institutional overhead (capped at 28%) and indirect costs. - Funds cannot be used to purchase therapeutic assets. - Maximum project length is 18 to 24 months. How to Apply For more information, please check the link: Applications Invited for Pfizer Medical Education Grant on Bladder Cancer (MIBC and la/mUC)

Funding organisation: Pfizer

Grant announcement listed on NGOBOX. Applications are made to the funding organisation — see the official announcement.